Endo International | Capitale Ordinario



Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 1.75B 2025-06
Amarin USD 20.8M 28K 2025-09
ANI Pharmaceuticals USD 21.73M 21.73M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Coherus Biosciences USD 12K 0 2025-03
Eli Lilly USD 946.83M 354.23M 2025-06
Heron Therapeutics USD 1.52M 14K 2024-09
Hikma Pharmaceutical USD 40M 0 2024-12
Ligand Pharmaceuticals USD 20K 0 2025-03
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pacira USD 44.9M 44.85M 2025-06
Perrigo USD 137.6M 0 2025-09
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 4K 0 2024-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Xeris Pharmaceuticals USD 165.53M 165.51M 2025-09
Zoetis USD 424.93M 16.54M 2025-12


Endo International Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.